The Institute of Pharmacology and Structural Biology (Institut de Pharmacologie et de Biologie Structurale, IPBS) is a joint CNRS-University of Toulouse research center occupying 12,000 m2 at the heart of the campus of Paul Sabatier University. The IPBS currently has a scientific and administrative staff of 250 people, including a large number of postdoctoral workers and postgraduate (masters and PhD) students, working in 16 research teams grouped into three departments (Cancer Biology, Structural Biology and Biophysics, Tuberculosis and Infection Biology), and four technological platforms. Our institute is a world leader in the discovery, characterization and validation of novel important pathways and therapeutic targets in the fields of cancer and infectious diseases, through the use of molecular and cellular biology approaches, together with in vivo experiments, including BSL-3-based studies of infectious diseases. It conducts state-of-the-art research in structural biology, proteomics, biophysics, cancerology, immunology and microbiology.